President Joe Biden recently held a star-studded fundraiser at Radio City Music Hall with his Democratic predecessors, Barack Obama and Bill Clinton. The event managed to raise over $26 million and attracted more than 5,000 supporters. The gathering had a high-profile guest list, with celebrities like Queen Latifah, Lizzo, Ben Platt, Cynthia Erivo, and Lea
0 Comments
Thailand’s Prime Minister, Srettha Thavisin, recently announced that the government is contemplating the introduction of a casino bill that could have significant implications for the country. The passing of such a bill by parliament could potentially lead to the creation of more jobs, increased state revenue, and the development of a large-scale entertainment project. While
0 Comments
The world of entertainment recently lost a beloved actress, Jennifer Leak, who passed away at the age of 76. Leak’s career began in the 1960s when she appeared in the film Yours, Mine and Ours alongside Tim Matheson. However, her talent extended beyond the silver screen. Leak was known for her strength, charm, and exceptional
0 Comments
Toyota Motor is currently considering expanding its U.S. truck lineup to potentially include all-electric or plug-in hybrid electric versions of its popular Tacoma and Tundra pickups. The decision comes as the automaker evaluates customer demand and responds to stricter federal emissions and fuel economy regulations. Jack Hollis, executive vice president of Toyota Motor North America,
0 Comments
FTX founder Sam Bankman-Fried was recently sentenced to 25 years in prison for his part in a massive fraud and conspiracy that led to the downfall of his cryptocurrency exchange and related hedge fund. The sentencing took place in a Manhattan federal court and was met with mixed reactions from both the prosecution and the
0 Comments
The recent approval of vadadustat (Vafseo) by the FDA for the treatment of chronic kidney disease (CKD)-related anemia in adults on dialysis has sparked mixed reactions within the medical community. This decision comes after Akebia Therapeutics’ second attempt at gaining approval for this indication, following an initial rejection due to concerns about the drug’s benefit-risk
0 Comments